GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-05-07: Form 6-K; Period of report 2015-05-07; Description BOARD AND COMMITTEE CHANGES; Document gsk201505076k.htm.
- 2015-05-06: Form 6-K; Period of report 2015-05-06; Description 1ST QUARTER RESULTS; Document gsk201505066k.htm.
- 2015-05-06: Form 6-K; Period of report 2015-05-06; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201505066k2.htm.
- 2015-05-01: Form 6-K; Period of report 2015-05-01; Description TOTAL VOTING RIGHTS; Document gsk201505016k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2015-05-07 | 6-K | 2015-05-07 | BOARD AND COMMITTEE CHANGES | gsk201505076k.htm |
| 2015-05-06 | 6-K | 2015-05-06 | 1ST QUARTER RESULTS | gsk201505066k.htm |
| 2015-05-06 | 6-K | 2015-05-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201505066k2.htm |
| 2015-05-01 | 6-K | 2015-05-01 | TOTAL VOTING RIGHTS | gsk201505016k.htm |
| 2015-04-30 | 6-K | 2015-04-30 | FDA APPROVES BREO ELLIPTA FOR ADULTS WITH ASTHMA | gsk201504306k2.htm |
| 2015-04-30 | 6-K | 2015-04-30 | DIRECTOR/PDMR SHAREHOLDING | gsk201504306k.htm |
| 2015-04-29 | 6-K | 2015-04-29 | DIRECTOR/PDMR SHAREHOLDING | gsk201504296k.htm |
| 2015-04-28 | 6-K | 2015-04-28 | GSK CANDIDATE VACCINE FOR PREVENTION OF SHINGLES | gsk201504286k1.htm |
| 2015-04-28 | 6-K | 2015-04-28 | DIRECTOR/PDMR SHAREHOLDING | gsk201504286k.htm |
| 2015-04-23 | 6-K | 2015-04-23 | DIRECTOR/PDMR SHAREHOLDING | gsk201504236k.htm |
| 2015-04-20 | 6-K | 2015-04-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201504206k4.htm |
| 2015-04-20 | 6-K | 2015-04-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201504206k3.htm |
| 2015-04-20 | 6-K | 2015-04-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201504206k2.htm |
| 2015-04-20 | 6-K | 2015-04-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201504206k.htm |
| 2015-04-14 | 6-K | 2015-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201504146k2.htm |
| 2015-04-14 | 6-K | 2015-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201504146k.htm |
| 2015-04-13 | 6-K | 2015-04-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201504136k4.htm |
| 2015-04-13 | 6-K | 2015-04-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201504136k3.htm |
| 2015-04-13 | 6-K | 2015-04-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201504136k2.htm |
| 2015-04-13 | 6-K | 2015-04-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201504136k.htm |
| 2015-04-10 | 6-K | 2015-04-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201504106k.htm |
| 2015-04-08 | 6-K | 2015-04-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201504086k.htm |
| 2015-04-01 | 6-K | 2015-04-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201504016k1.htm |
| 2015-04-01 | 6-K | 2015-04-01 | TOTAL VOTING RIGHTS | gsk201504016k.htm |
| 2015-03-30 | 6-K | 2015-03-30 | DIRECTOR/PDMR SHAREHOLDING | gsk201503306k.htm |
| 2015-03-25 | 6-K | 2015-03-25 | NOTICE OF AGM | gsk201503256k.htm |
| 2015-03-20 | 6-K | 2015-03-19 | US FDA ADVISORY COMMITTEE ON BREO ELLIPTA | gsk201503196k1.htm |
| 2015-03-19 | 6-K | 2015-03-19 | DIRECTOR DECLARATION | gsk201503196k.htm |
| 2015-03-16 | 6-K | 2015-03-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201503166k.htm |
| 2015-03-13 | 6-K | 2015-03-13 | GSK INTENDS TO SELL PART HOLDING IN ASPEN | gsk201503136k1.htm |
| 2015-03-13 | 6-K | 2015-03-13 | GSK COMPLETES PARTIAL SALE OF ASPEN | gsk201503136k.htm |
| 2015-03-11 | 6-K | 2015-03-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201503116k1.htm |
| 2015-03-11 | 6-K | 2015-03-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201503116k.htm |
| 2015-03-09 | 6-K | 2015-03-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201503096k.htm |
| 2015-03-06 | 6-K | 2015-03-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201503066k.htm |
| 2015-03-02 | 6-K | 2015-03-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201503026k4.htm |
| 2015-03-02 | 6-K | 2015-03-02 | ANNUAL REPORT 2014 ON FORM 20-F | gsk201503026k3.htm |
| 2015-03-02 | 6-K | 2015-03-02 | TOTAL VOTING RIGHTS | gsk201503026k2.htm |
| 2015-03-02 | 6-K | 2015-03-02 | GSK COMPLETES MAJOR THREE-PART TRANSACTION | gsk201503026k.htm |
| 2015-02-26 | 6-K | 2015-02-26 | DIRECTORATE CHANGE | gsk201502266k2.htm |
| 2015-02-26 | 6-K | 2015-02-26 | ANNUAL FINANCIAL REPORT | gsk201502266k.htm |
| 2015-02-25 | 6-K | 2015-02-25 | UPDATE ON THREE-PART TRANSACTION WITH NOVARTIS | gsk201502256k.htm |
| 2015-02-20 | 6-K | 2015-02-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201502206k2.htm |
| 2015-02-20 | 6-K | 2015-02-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201502206k.htm |
| 2015-02-19 | 6-K | 2015-02-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201502196k2.htm |
| 2015-02-19 | 6-K | 2015-02-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201502196k.htm |
| 2015-02-18 | 6-K | 2015-02-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201502186k1.htm |
| 2015-02-18 | 6-K | 2015-02-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201502186k.htm |
| 2015-02-17 | 6-K | 2015-02-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201502176k3.htm |
| 2015-02-17 | 6-K | 2015-02-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201502176k2.htm |
| 2015-02-17 | 6-K | 2015-02-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201502176k.htm |
| 2015-02-17 | 6-K | 2015-02-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201502166k.htm |
| 2015-02-13 | 6-K | 2015-02-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201502136k1.htm |
| 2015-02-13 | 6-K | 2015-02-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201502136k.htm |
| 2015-02-12 | 6-K | 2015-02-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201502126k2.htm |
| 2015-02-12 | 6-K | 2015-02-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201502126k1.htm |
| 2015-02-12 | 6-K | 2015-02-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201502126k.htm |
| 2015-02-11 | 6-K | 2015-02-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201502116k.htm |
| 2015-02-06 | 6-K | 2015-02-06 | POSITIVE RESULTS FROM PHASE III COMBI-D STUDY | gsk201502066k.htm |
| 2015-02-05 | 6-K | 2015-02-05 | ACCELERATED BOOKBUILD OFFERING - GENMAB A/S | gsk201502056k2.htm |
| 2015-02-05 | 6-K | 2015-02-05 | COMPLETION OF ACCELERATED BOOKBUILD OFFERING | gsk201502056k.htm |
| 2015-02-04 | 6-K | 2015-02-02 | FINAL RESULTS | gsk201502046k.htm |
| 2015-02-02 | 6-K | 2015-02-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201502026k2.htm |
| 2015-02-02 | 6-K | 2015-02-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201502026k.htm |
| 2015-01-28 | 6-K | 2015-01-28 | DIRECTOR DECLARATION | gsk201501286k2.htm |
| 2015-01-28 | 6-K | 2015-01-28 | REGULATORY UPDATE | gsk201501286k1.htm |
| 2015-01-28 | 6-K | 2015-01-27 | DIRECTOR/PDMR SHAREHOLDING | gsk201501286k.htm |
| 2015-01-27 | 6-K | 2015-01-27 | BOARD COMMITTEE CHANGES | gsk201501276k.htm |
| 2015-01-22 | 6-K | 2015-01-22 | DIRECTOR/PDMR SHAREHOLDING | gsk201501226k.htm |
| 2015-01-20 | 6-K | 2015-01-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201501206k1.htm |
| 2015-01-20 | 6-K | 2015-01-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201501206k.htm |
| 2015-01-20 | 6-K | 2015-01-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201501196k2.htm |
| 2015-01-20 | 6-K | 2015-01-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201501196k3.htm |
| 2015-01-20 | 6-K | 2015-01-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201501196k1.htm |
| 2015-01-20 | 6-K | 2015-01-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201501196k.htm |
| 2015-01-15 | 6-K/A | 2015-01-15 | DIRECTOR/PDMR SHAREHOLDING- AMENDMENT | gsk201501156ka.htm |
| 2015-01-13 | 6-K | 2015-01-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201501136k.htm |
| 2015-01-12 | 6-K | 2015-01-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201501126k1.htm |
| 2015-01-12 | 6-K | 2015-01-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201501126k.htm |
| 2015-01-09 | 6-K | 2015-01-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201501096k3.htm |
| 2015-01-09 | 6-K | 2015-01-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201501096k2.htm |
| 2015-01-09 | 6-K | 2015-01-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201501096k.htm |
| 2015-01-05 | 6-K | 2015-01-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201501056k4.htm |
| 2015-01-05 | 6-K | 2015-01-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201501056k3.htm |
| 2015-01-05 | 6-K | 2015-01-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201501056k2.htm |
| 2015-01-05 | 6-K | 2015-01-05 | TOTAL VOTING RIGHTS | gsk201501056k.htm |